No Benefit of Colchicine in Large MIs: CLEAR SYNERGY Trial

Several randomized trials have shown reductions in MACE with colchicine in the treatment of coronary artery disease.
The CLEAR SYNERGY (OASIS 9) trial showed that in patients with acute MI undergoing PCI, daily treatment with colchicine did not reduce MACE at 5 years compared with placebo.